메뉴 건너뛰기




Volumn 6, Issue , 2006, Pages

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: Results of a phase II trial

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

EID: 33745104452     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-125     Document Type: Article
Times cited : (34)

References (26)
  • 1
    • 16544371710 scopus 로고    scopus 로고
    • Enrollment of elderly patients in clinical trials for cancer drug registration: A 7-year experience by the US Food and Drug Administration
    • Talarico L, Chen G, Pazdur R: Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004, 22:4626-31.
    • (2004) J Clin Oncol , vol.22 , pp. 4626-4631
    • Talarico, L.1    Chen, G.2    Pazdur, R.3
  • 3
    • 2442494952 scopus 로고    scopus 로고
    • High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: A report from the Italian Group for the Study of Digestive Tract Cancer [GIS-CAD]
    • Cascinu S, Scartozzi M, Labianca R, Catalano V, Silva RR, Barni S, Zaniboni A, D'Angelo A, Salvagni S, Martignoni G, Beretta GD, Graziano F, Berardi R, Franciosi V: High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer [GIS-CAD]. Br J Cancer 2004, 8:1521-5.
    • (2004) Br J Cancer , vol.8 , pp. 1521-1525
    • Cascinu, S.1    Scartozzi, M.2    Labianca, R.3    Catalano, V.4    Silva, R.R.5    Barni, S.6    Zaniboni, A.7    D'Angelo, A.8    Salvagni, S.9    Martignoni, G.10    Beretta, G.D.11    Graziano, F.12    Berardi, R.13    Franciosi, V.14
  • 4
    • 0242575737 scopus 로고    scopus 로고
    • A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer
    • Graziano F, Santini D, Testa E, Catalano V, Beretta GD, Mosconi S, Tonini G, Lai V, Labianca R, Cascinu S: A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer 2003, 8:1428-32.
    • (2003) Br J Cancer , vol.8 , pp. 1428-1432
    • Graziano, F.1    Santini, D.2    Testa, E.3    Catalano, V.4    Beretta, G.D.5    Mosconi, S.6    Tonini, G.7    Lai, V.8    Labianca, R.9    Cascinu, S.10
  • 11
    • 21244437063 scopus 로고    scopus 로고
    • Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
    • Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR, Ward C, Iveson T, Nicolson M, Hickish T, Hill M, Oates J: Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF. Br J Cancer 2005, 92:1976-83.
    • (2005) Br J Cancer , vol.92 , pp. 1976-1983
    • Sumpter, K.1    Harper-Wynne, C.2    Cunningham, D.3    Rao, S.4    Tebbutt, N.5    Norman, A.R.6    Ward, C.7    Iveson, T.8    Nicolson, M.9    Hickish, T.10    Hill, M.11    Oates, J.12
  • 12
    • 0030935080 scopus 로고    scopus 로고
    • Functional health status as a predictor of mortality in men and women over 65
    • Scott WK, Macera CA, Cornman CB, Sharpe PA: Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997, 50:291-296.
    • (1997) J Clin Epidemiol , vol.50 , pp. 291-296
    • Scott, W.K.1    Macera, C.A.2    Cornman, C.B.3    Sharpe, P.A.4
  • 13
    • 0034327146 scopus 로고    scopus 로고
    • General guidelines for management of older patients with cancer
    • Balducci L, Yates J: General guidelines for management of older patients with cancer. Oncology 2000, 14:221-227.
    • (2000) Oncology , vol.14 , pp. 221-227
    • Balducci, L.1    Yates, J.2
  • 16
    • 0025213358 scopus 로고
    • High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer: A phase II study in elderly patients or patients with cardiac risk
    • Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schober C, Link H, Meyer HJ, Lucke B: High dose folinic acid/etoposide/ 5-fluorouracil in advanced gastric cancer: a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 1990, 8:65-70.
    • (1990) Invest New Drugs , vol.8 , pp. 65-70
    • Wilke, H.1    Preusser, P.2    Fink, U.3    Achterrath, W.4    Lenaz, L.5    Stahl, M.6    Schober, C.7    Link, H.8    Meyer, H.J.9    Lucke, B.10
  • 17
    • 0028284056 scopus 로고
    • Etoposide, leucovorin 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: A pilot study
    • Cascinu S, Fedeli A, Catalano G: Etoposide, leucovorin 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. Cancer Chemother Pharmacol 1994, 34:72-74.
    • (1994) Cancer Chemother Pharmacol , vol.34 , pp. 72-74
    • Cascinu, S.1    Fedeli, A.2    Catalano, G.3
  • 18
    • 0029013091 scopus 로고
    • Intensive weekly chemotherapy for elderly gastric cancer patients using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and gluthatione with the support of G-CSF
    • Cascinu G, Catalano G: Intensive weekly chemotherapy for elderly gastric cancer patients using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and gluthatione with the support of G-CSF. Tumori 1995, 81:32-35.
    • (1995) Tumori , vol.81 , pp. 32-35
    • Cascinu, G.1    Catalano, G.2
  • 19
    • 0028876887 scopus 로고
    • Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy
    • Di Bartolomeo M, Bajetta E, de Braud F, Bochicchio AM, Gebbia V, Bozzetti F, Doci R, Bonfanti G, Cozzaglio L: Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology 1995, 52:41-44.
    • (1995) Oncology , vol.52 , pp. 41-44
    • Di Bartolomeo, M.1    Bajetta, E.2    de Braud, F.3    Bochicchio, A.M.4    Gebbia, V.5    Bozzetti, F.6    Doci, R.7    Bonfanti, G.8    Cozzaglio, L.9
  • 21
    • 0036516622 scopus 로고    scopus 로고
    • A phase II study of doxifluridine in elderly patients with advanced gastric cancer: The Japan Clinical Oncology Group study [JCOG 9410]
    • Ikeda N, Shimada Y, Ohtsu A, Boku N, Tsuji Y, Saito H, Koizumi W, Iwase H, Yoshida S, Fukuda H: A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group study [JCOG 9410]. Jpn J Clin Oncol 2002, 32:90-94.
    • (2002) Jpn J Clin Oncol , vol.32 , pp. 90-94
    • Ikeda, N.1    Shimada, Y.2    Ohtsu, A.3    Boku, N.4    Tsuji, Y.5    Saito, H.6    Koizumi, W.7    Iwase, H.8    Yoshida, S.9    Fukuda, H.10
  • 22
    • 0037352255 scopus 로고    scopus 로고
    • Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer
    • Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK: Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol 2003, 14:383-387.
    • (2003) Ann Oncol , vol.14 , pp. 383-387
    • Kim, D.Y.1    Kim, J.H.2    Lee, S.H.3    Kim, T.Y.4    Heo, D.S.5    Bang, Y.J.6    Kim, N.K.7
  • 26
    • 0033909505 scopus 로고    scopus 로고
    • Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
    • Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Flanker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000, 18:2648-2657.
    • (2000) J Clin Oncol , vol.18 , pp. 2648-2657
    • Vanhoefer, U.1    Rougier, P.2    Wilke, H.3    Ducreux, M.P.4    Lacave, A.J.5    Van Cutsem, E.6    Flanker, M.7    Santos, J.G.8    Piedbois, P.9    Paillot, B.10    Bodenstein, H.11    Schmoll, H.J.12    Bleiberg, H.13    Nordlinger, B.14    Couvreur, M.L.15    Baron, B.16    Wils, J.A.17


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.